Provention Bio, INC.
Biopharmaceutical company
Based in NJ
AI Overview
With $220K in lobbying spend across 11 quarterly filings, Provention Bio, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $70K |
| 2022 | $110K |
| 2023 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Provention Bio, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Access to innovations for autoimmune diseases; disease and screening education.
Issues related to type 1 diabetes population screening and drug therapies.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.